We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Tick-Borne Disease Found

By LabMedica International staff writers
Posted on 17 Sep 2012
A new Phlebovirus, dubbed the "Heartland virus," is being spread to people by ticks common in the Southeastern part of the USA.

The only tickborne Phlebovirus known to cause human disease is severe fever with thrombocytopenia syndrome virus (SFTSV), which was recently identified in central and northeastern China. More...


Scientists at US Centers of Disease Control and Prevention (CDC; Atlanta, GA, USA) collected leukocytes from two patients on day two of hospitalization. Both men had fever, fatigue, diarrhea, and low levels of blood platelets and white blood cells and had reportedly been bitten by ticks. The symptoms are similar to those of ehrlichiosis, a relatively common tick-borne disease that is caused by bacteria.

The leukocytes were inoculated onto cultures of macrophage-monocyte cell line from a dog with malignant histiocytosis (DH82). Total ribonucleic acid (RNA) was isolated from infected culture media and subjected to next-generation sequencing using quantitative reverse transcription PCR (qRT-PCR). The resulting full-length genome sequences were found to be similar to those of phleboviruses in the Bunyaviridae family, which are single-stranded, negative-sense RNA viruses comprised of three genome segments.

Immunohistochemical staining of the bone marrow of one patient revealed the virus nucleocapsid protein in large mononuclear cells that did not resemble mature granulocytes, erythroid cells, or megakaryocytes. Patient serum samples were tested for the presence of antibodies reactive to the novel virus. In October 2011, more than two years after the onset of infection, blood was collected from both patients and serum samples were tested on enzyme-linked immunosorbent assay (ELISA) to detect immunoglobulin G (IgG) reactive with virus antigen made from inactivated virus-infected cell lysate. Both serum samples were strongly positive, with titers of more than 6,400.

Laura K. McMullan, PhD, and her colleagues concluded that although these two patients had severe disease, the incidence of infection with the novel virus and range of disease severity is currently unknown. This virus could be a more common cause of human illness than is currently recognized. They warn health professionals to be on the lookout for people who fall ill after getting tick bites and who do not get better after antibiotic treatment. The study was published on August 30, 2102, in the New England Journal of Medicine (NEJM).

Related Links:
US Centers of Disease Control and Prevention



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.